About
Marius Pharmaceuticals develops oral testosterone therapies for men with low testosterone levels due to medical conditions. Their main product, KYZATREX, is an FDA-approved capsule that supports heart function, bone and muscle strength, and metabolic efficiency. The company focuses on precise hormone replacement to enhance overall vitality.
They pursue research into testosterone's role in fertility, muscle preservation, and women's health. Partnerships with urology practices and academic centers enable integrated access through in-office dispensaries. This approach prioritizes patient compliance and metabolic health optimization.
KYZATREX uses a proprietary lymphatic delivery system, avoiding liver toxicity common in other oral forms. Ongoing studies explore its use in surgery recovery and older men. Marius aims for sustainable improvements in hormone-related well-being.
Longevity Contribution
- Proprietary softgel formulation absorbed via lymphatic system, bypassing liver toxicity.
- Cash-only prescription model through urologic in-office dispensaries, avoiding insurance hurdles.
- Focus on metabolic health beyond symptoms, targeting heart, bone, muscle, and efficiency.
- Expanding research into fertility, women's health, and surgical recovery applications.